299 related articles for article (PubMed ID: 18362298)
41. Circulating ghrelin concentrations in the polycystic ovary syndrome.
Orio F; Lucidi P; Palomba S; Tauchmanova L; Cascella T; Russo T; Zullo F; Colao A; Lombardi G; De Feo P
J Clin Endocrinol Metab; 2003 Feb; 88(2):942-5. PubMed ID: 12574237
[TBL] [Abstract][Full Text] [Related]
42. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
[TBL] [Abstract][Full Text] [Related]
43. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
44. Adiponectin and resistin concentrations after glucose load in adolescents with polycystic ovary syndrome.
Güven A; Ozgen T; Aliyazicioğlu Y
Gynecol Endocrinol; 2010 Jan; 26(1):30-8. PubMed ID: 19639497
[TBL] [Abstract][Full Text] [Related]
45. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Apr; 91(4):1508-12. PubMed ID: 16464947
[TBL] [Abstract][Full Text] [Related]
46. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
47. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
[TBL] [Abstract][Full Text] [Related]
48. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
[TBL] [Abstract][Full Text] [Related]
49. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
González F; Minium J; Rote NS; Kirwan JP
J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
[TBL] [Abstract][Full Text] [Related]
50. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
51. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
52. Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity.
Altuğ Şen T; Köken R; Narcı A; Yılmazer M
J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):211-7. PubMed ID: 21458334
[TBL] [Abstract][Full Text] [Related]
53. Incretin levels in polycystic ovary syndrome.
Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
[TBL] [Abstract][Full Text] [Related]
54. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
55. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
56. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.
Aydin K; Arusoglu G; Koksal G; Cinar N; Aksoy DY; Yildiz BO
Clin Endocrinol (Oxf); 2014 Oct; 81(4):588-92. PubMed ID: 24730585
[TBL] [Abstract][Full Text] [Related]
57. Polycystic ovary syndrome and abnormalities in glucose tolerance.
Bhattacharya SM
Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
[TBL] [Abstract][Full Text] [Related]
58. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
59. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.
Phelan N; O'Connor A; Kyaw-Tun T; Correia N; Boran G; Roche HM; Gibney J
J Clin Endocrinol Metab; 2010 Aug; 95(8):3933-9. PubMed ID: 20519354
[TBL] [Abstract][Full Text] [Related]
60. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
